The Choice of Immunotherapy and PARP Inhibitor for Gynecological Cancer
Charlotte Haslund, MD, chief oncologist at the Department of Oncology, Aalborg University Hospital, specializing in gynecological cancer, presented highlights and Danish perspectives on ovarian cancer at the Danish Evening at ESMO 2024.